Skip to Main Content
Contribute Try STAT+ Today

Rise and shine, everyone, another busy day is on the way. How do we know? The clues are surrounding us: The short person is hovering over a laptop, the official mascot is bounding about the official grounds in search of creatures, and the coffee kettle is emitting its usual high-pitched whistle. All of which is to say that the time has come to get cracking. So once again, we offer you a menu of tidbits to devour. We hope your journey today is productive and pleasant. Meanwhile, do keep in touch. And stay safe — wear a mask. …

Six in 10 Americans are somewhat or very likely to get a Covid-19 vaccine if doing so would lower the risk of becoming infected by about half, according to a new survey from STAT and The Harris Poll. The poll also found more Americans say they are likely to get a vaccine, practice social distancing, and wear a mask if they or someone they know has contracted Covid-19. The poll, which surveyed 1,954 adults online from Oct. 29-31, suggests that even a more effective vaccine wouldn’t have an outsized impact on the public’s willingness to be immunized.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.